MYO18B and cancer: In the context of CTAs, we have identified the regulation of MYO18B mRNA (another cancer testis antigen) by miR-520G in Hep3B cells40, which further supports the notion that the p53 defective background is associated with CTA expression through C19MC miRNAs.